BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7503646)

  • 1. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assays for botulinum toxin and antitoxins.
    Shone C; Appleton N; Wilton-Smith P; Hambleton P; Modi N; Gatley S; Melling J
    Dev Biol Stand; 1986; 64():141-5. PubMed ID: 3792644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
    Hörmeyer E; Schultz A; Sailer J; Opitz G; Stünkel K; Petzoldt K
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):16-9. PubMed ID: 3885940
    [No Abstract]   [Full Text] [Related]  

  • 8. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 10. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH; Andreadis JD
    J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody to type F Clostridium botulinum toxin.
    Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
    Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulin toxin A detection by means of immunofluorescent adsorption reaction in experimentally contaminated food products].
    Banasiewicz R; Reiss J
    Rocz Panstw Zakl Hig; 1975; 26(6):649-61. PubMed ID: 1105753
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.